Phase 1 study

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor Tafalgie Therapeutics
Registry number NCT06789861
Started 23 May 2025 Today 16 October 2026 Estimated completion 1 October 2026

Past estimated completion. The registry still lists this trial as open, and the date it gave for finishing has been and gone. Confirm with the official record before you act on it.

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Cmax & PARC Adelaide SA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 55 Years
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 94

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Main inclusion criteria for Parts A and B:

* Non-smoker for the confinement period of the study.

* Medically healthy and without clinically significant abnormalities.

* Negative screen for alcohol and drugs of abuse.

* No history of psychiatric disorders.

* Female participants of non-childbearing potential must be post-menopausal or surgically sterile at least 3 months prior to dosing.

* Sexually active females of childbearing potential and non-sterile males must be willing to use an acceptable contraceptive method throughout the study.

* Able to understand the study procedures and provide signed informed consent to participate in the study in English.

Main exclusion criteria for Parts A and B:

* History of clinically significant asthma, anaphylaxis, major medical, psychiatric illness or surgery.

* Acute or chronic clinically relevant systemic disease or disorder.

* Renal insufficiency

* History of drug or alcohol consumption abuse.

* Drinking excessive amounts of tea, coffee, chocolate and/or beverage containing caffeine.

* Have used any investigational drug or participated in any clinical trial within 4 weeks prior to screening.

* Unable to refrain from strenuous exercise.

* Participant who has received blood or plasma derivatives, who had a surgery or who has given blood within 4 weeks prior to the screening visit or has planned to give blood or sperm within the 90 days following the study.

* Pregnant or lactating female participant.

Dates on the record

Started 23 May 2025
Estimated completion 1 October 2026
Registry last updated 18 March 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 18 March 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.